Arch Biopartners Announces Listing on OTCQB Exchange

Arch Biopartners (TSX Venture:ARCH) (OTCQB:ACHFF) a portfolio-based biotechnology company, announced that the Company’s common shares have been approved to begin trading today on the OTCQB Venture Market (OTCQB) under the ticker ACHFF.

As quoted in the press release:

“Listing on the OTCQB will help our company engage a larger network of U.S. investors and media partners. It also provides U.S. investors with improved market access to trade our shares and access our public filings, similar to what is available to investors in our home exchange,” said Richard Muruve, CEO of Arch.

The OTCQB is recognized by the U.S. Securities Exchange Commission (SEC) as an established public market. Eligible companies do not have Sarbanes-Oxley and SEC Reporting requirements to trade on OTCQB, bypassing costly and duplicative NYSE and NASDAQ listing requirements. The OTCQB market is primarily for early-stage and developing companies. To be eligible, international companies must be listed on a qualified foreign stock exchange, be current in their regulatory filings and complete an annual verification and management certification.

Click here to read the full press release.